Summit Therapeutics Inc. (SMMT) Total liabilities 2018–2024
Summit Therapeutics Inc. (SMMT) total liabilities at each fiscal year-end, per SEC filings.
$46.8MFY2024 · since FY2018: $82.7M → $46.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $46.8M | -62.6% |
| FY2023 | $125.3M | -76.7% |
| FY2022 | $537.5M | +1686.4% |
| FY2021 | $30.1M | +30.6% |
| FY2020 | $23.0M | -3.0% |
| FY2019 | $23.8M | -71.3% |
| FY2018 | $82.7M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice